Loblaw Companies Limited · TSX:L
Loblaw Companies — Q1 2023 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Mar 25, 2023
Slide 1: Supplementary Slides Q1 2023
SUPPLEMENTARY SLIDES Q1 2023 For the periods ended March 25, 2023 and March 26, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q1 2023 (In CAD millions unless otherwise noted) Q1 2023 Q1 2022 % Change (1) Consolidated Revenue $12,995 $12,262 ↑ +6.0% Adjusted EBITDA $1,448 $1,343 ↑ +7.8% Adjusted EBITDA Margin 11.1% 11.0% ↑ +10 bps Adjusted Net Earnings Avaliable to Common Shareholders $5
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q1 2023 (In CAD millions unless otherwise noted) Q1 2023 Q1 2022 % Change (1) Total Retail Revenue $12,735 $12,045 ↑ +5.7% Retail Revenue - Food $9,011 $8,682 ↑ +3.8% Retail Revenue - Drug $3,724 $3,363 ↑ +10.7% Pharmacy and Healthcare Services $1,924 $1,724 ↑
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q1 2023 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +3.1% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +7.4